Ann Arbor residents grapple with ADHD medication shortages and recalls

For Ann Arbor residents and University of Michigan students, filling a prescription for attention-deficit/hyperactivity disorder medication has long been an exercise in uncertainty. Even before the Oct. 28 recall of lisdexamfetamine dimesylate capsules, commonly known as Vyvanse, pharmacies in Ann Arbor and across the country have struggled for more than two years to keep key…

Read More

New study explores how ADHD symptoms relate to menopause in midlife women

Women with attention-deficit/hyperactivity disorder (ADHD) often navigate a range of challenges that extend far beyond childhood. One area of increasing interest is how this condition interacts with the menopausal transition, a period marked by significant hormonal and cognitive shifts. A new study published in the Journal of Attention Disorders offers an in-depth look into this…

Read More

Discontinuation of ADHD medication more common in children with underweight

Children who are underweight are more likely to stop taking their ADHD medication within a year. These are the findings of a study conducted at the University of Gothenburg on methylphenidate, a common pharmacological treatment in ADHD. Behind the discontinuations are clear differences in dosage that can also be linked to gender and age.

Read More

Omega-3 deficit linked to ADHD symptoms in Palestinian adolescents

Attention-deficit/hyperactivity disorder (ADHD) symptoms are influenced by socioeconomic factors in regions affected by conflict and resource limitations, a new study focusing on non-Western populations has found. The study also revealed that lower omega-3 fatty acid intake is significantly associated with higher ADHD symptom scores in Palestinian adolescents, reflecting findings from other research conducted in Western…

Read More

ADHD and Mild Cognitive Impairment/Early Dementia: A Clinical Reality

Key Takeaways: ADHD prevalence in older adults is estimated between 2.18% and 3.5%, with treatment rates significantly lower than diagnosis rates. Diagnosing ADHD in older adults is complex due to symptom overlap with other cognitive disorders and limited clinical training. Limited research on ADHD medications in older adults suggests stimulants may improve symptoms with manageable…

Read More

US jury convicts founder of ADHD startup in Adderall fraud scheme

Nov 19 (Reuters) – The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of alleged illegal drug distribution by a telehealth company. Ruthia He, who founded Done, and David Brody were each found guilty…

Read More